Diagnosis
- Palpate carotid for more reliable measure of pulse.
- Suspect paroxysmal AF if symptoms are episodic and last less than 48 hours
- Absence of irregular pulse makes AF unlikely. Its presence does not reliably indicate AF.
- ECG in AF has – no P-wave, a chaotic baseline and an irregular ventricular rate
- Rate is usually 160-180 BPM, but can be lower in typically in asymptomatic patients
- If paroxysmal AF suspected and not found on ECG
- Arrange ambulatory ECG
- 24 hour ECG if symptoms < 24h apart, or event recorder ECG/7 Day Holter if > 24h apart
Management
- Onset in last 48h
- If haemodynamic instability (Pulse > 150BPM) and/or Low BP (systolic < 90) or LOC, severe dizziness, chest pains or SOB -> A&E for electrical cardioversion
- Else – consider management in primary care if appropriate or refer to acute medical unit for immediate cardioversion
- if has suspected decompensated HF, seek specialist advice on use of BB and avoid CCB.
- Most people with symptomatic acute onset AF are initially managed in secondary care.
- For others (including paroxysmal AF)
- Admit if – haemodynamic instability, or other serious associated condition, e.g. CVA, PE, pneumonia, thyrotoxicosis, severe HF
- Else – Screen for causes of AF and manage or refer as appropriate
- Cardiac – HTN, Valve disease, HF, IHD
- Respiratory – LRTI, Lung cancer
- Systemic causes – Alcohol, hyperthyroidism, Electrolyte imbalance (U&E, calcium and magnesium), infection, DM
- Cardiology referral needed if
- A pre-excitation syndrome e.g. WPW syndrome
- Valve disease associated with AF
- HF suspected
- For consideration of pharmacological or electrical rhythm control (Cardioversion)
- AF has reversible cause – e.g. LRTI
- HF caused or worsened by AF
- Primary care management
- Assess stroke risk using CHA2DS2VASc assessment tool
- Assess bleeding risk using ORBIT bleeding risk tool
- If anticoagulation necessary
- Offer DOAC
- Apixaban, Rivaroxaban, Dabigatran and Edoxaban are all suitable
- Apixaban and Rivaroxaban are reversed by Andexanet alfa and Dabigatran is reversed by Idarucizumab. Edoxaban has no reversing agent.
- Do not withhold solely because of age or falls risk
- Apixaban, Rivaroxaban, Dabigatran and Edoxaban are all suitable
- Warfarin if DOAC not suitable
- If anticoagulation is contraindicated – consider combination Aspirin and Clopidogrel
- Offer DOAC
- Rate control
- 1st line – BB (other than sotalol) or CCB (Diltiazem or verapamil note avoid in HF with reduced EF)
- 2nd line – Digoxin (for non-paroxysmal AF if they do little/no exercise or others rate limiting drugs ruled out)
- Arrange follow up in 1 week
- Aim 60-80 BMP at rest, and 90-115 at moderate exercise
- Consider referral for cardioversion if symptoms continue or rate control fails – to see specialist within 4 weeks